The 28th of June 2022, in a virtual setting, the 1st NEUROSENSE Summit took place. During the morning, the partners of the NEUROSENSE Consortium met with the External Expert Advisory Board (EEAB) under the scope of “Get Inspired” to set the ground for the activities along the four-year duration of the EU Project. As patient […]

Project NEUROSENSE (NEUROendocrine SENSor for Sudden Unexpected Death in Epilepsy prediction and prevention) has been approved in the highly-competitive context of EU Horizon EUROPE Pathfinder Open call, with 4M€ funding. The project will be developed under the leadership of i3S – Instituto de Investigação e Inovação em Saúde da Universidade do Porto with Portuguese Biotech […]